{"id":3398,"date":"2026-09-23T20:15:34","date_gmt":"2026-09-23T18:15:34","guid":{"rendered":"https:\/\/energianucleare.eu\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/"},"modified":"2026-09-23T20:15:34","modified_gmt":"2026-09-23T18:15:34","slug":"standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine","status":"publish","type":"post","link":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/","title":{"rendered":"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine"},"content":{"rendered":"<p><strong>StandardX<\/strong> has closed a <strong>\u00a310 million seed round<\/strong> to build what it describes as the world&#8217;s first scalable isotope refinery. The London-based startup, founded in 2025 by two nuclear engineers, aims to solve one of the energy and healthcare sectors&#8217; quietest yet most pressing bottlenecks: the chronic scarcity of rare isotopes \u2014 materials that are essential both for cancer diagnosis and treatment and for fuelling the next generation of fusion reactors.<\/p>\n<p>The round was led by <strong>Vsquared Ventures<\/strong> and <strong>East X Ventures<\/strong>, two European deep tech funds with portfolios including Neura Robotics and Proxima Fusion. Joining the lead investors are firstminute capital, the <strong>UK Innovation and Science Seed Fund<\/strong> (UKI2S), Brevan Howard Macro Venture, and Geometry. The capital will be used to build out the team, secure an industrial site in London, and advance the design and construction of the first particle accelerator-based refinery system.<\/p>\n<p>Production will begin with oncology isotopes, with a dual purpose: supplying hospitals with the materials that already underpin diagnostic and therapeutic procedures, while also developing isotopes for next-generation radiopharmaceuticals \u2014 some of which do not yet exist in commercial form. <strong>StandardX<\/strong> plans to deliver its first isotopes to a medical research partner in 2027 and reach industrial-scale production from 2029. The backdrop is stark: in May 2026, the UK met only 69.6% of its national cancer treatment target, with part of that shortfall directly attributable to isotope shortages rather than any scientific limitation.<\/p>\n<p>The same accelerator-based platform is designed to scale towards other advanced applications. The most significant for the energy sector is <strong>tritium<\/strong>, the fuel of nuclear fusion: only around 25 kilograms exist worldwide, yet a single fusion plant consumes tens of kilograms per year to operate. <strong>StandardX<\/strong> has already signed agreements with fusion developers to support their tritium needs. CEO Richard Pearson and CTO Ross Allen \u2014 both with track records building startups in the nuclear space, with Pearson previously at Kyoto Fusioneering \u2014 designed the company around a clear concept: a modular, portable system that enables isotope production close to the point of use and allows output to be adjusted in line with demand.<\/p>\n<p><strong>StandardX<\/strong>&#8216;s approach stands out from competitors precisely because of this flexibility. Most existing players focus on a handful of isotopes or rely on a single production method; the London refinery instead targets a shared platform capable of generating multiple types of materials. Today&#8217;s global isotope supply chain is fragmented, reliant on ageing facilities, and concentrated in just a few sites. If the roadmap holds, by the end of the decade Europe could have a domestic, resilient source of materials that currently arrive from afar and in insufficient quantities \u2014 for both medicine and the fusion reactors now edging closer to the grid.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UK startup StandardX has closed a \u00a310 million seed round to build what it calls the world&#8217;s first scalable isotope refinery, targeting hospitals and fusion reactors. First medical deliveries are expected in 2027, with industrial-scale production from 2029.<\/p>\n","protected":false},"author":25,"featured_media":3395,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-3398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine - Energia nucleare<\/title>\n<meta name=\"description\" content=\"StandardX raises \u00a310M to build a rare isotope refinery for oncology and nuclear fusion. First deliveries in 2027, industrial scale from 2029.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine - Energia nucleare\" \/>\n<meta property=\"og:description\" content=\"StandardX raises \u00a310M to build a rare isotope refinery for oncology and nuclear fusion. First deliveries in 2027, industrial scale from 2029.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Energia nucleare\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-23T18:15:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/energianucleare.eu\/wp-content\/uploads\/2026\/09\/publish_09761b943ad14df6b0b82f9228258e13.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redazione Energia Nucleare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redazione Energia Nucleare\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/\"},\"author\":{\"name\":\"Redazione Energia Nucleare\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/#\\\/schema\\\/person\\\/2c3f466ad139658dfa60c575cf287fb7\"},\"headline\":\"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine\",\"datePublished\":\"2026-09-23T18:15:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/\"},\"wordCount\":457,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/energianucleare.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/publish_09761b943ad14df6b0b82f9228258e13.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/\",\"url\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/\",\"name\":\"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine - Energia nucleare\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/energianucleare.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/publish_09761b943ad14df6b0b82f9228258e13.jpg\",\"datePublished\":\"2026-09-23T18:15:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/#\\\/schema\\\/person\\\/2c3f466ad139658dfa60c575cf287fb7\"},\"description\":\"StandardX raises \u00a310M to build a rare isotope refinery for oncology and nuclear fusion. First deliveries in 2027, industrial scale from 2029.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/energianucleare.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/publish_09761b943ad14df6b0b82f9228258e13.jpg\",\"contentUrl\":\"https:\\\/\\\/energianucleare.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/publish_09761b943ad14df6b0b82f9228258e13.jpg\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/\",\"name\":\"Energia nucleare\",\"description\":\"Notizie sul nucleare\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/#\\\/schema\\\/person\\\/2c3f466ad139658dfa60c575cf287fb7\",\"name\":\"Redazione Energia Nucleare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7573bf636adfceb968c63d469c0889af0a78eb4935f321c17f76df121e056a6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7573bf636adfceb968c63d469c0889af0a78eb4935f321c17f76df121e056a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7573bf636adfceb968c63d469c0889af0a78eb4935f321c17f76df121e056a6?s=96&d=mm&r=g\",\"caption\":\"Redazione Energia Nucleare\"},\"url\":\"https:\\\/\\\/energianucleare.eu\\\/en\\\/author\\\/redazione\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine - Energia nucleare","description":"StandardX raises \u00a310M to build a rare isotope refinery for oncology and nuclear fusion. First deliveries in 2027, industrial scale from 2029.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/","og_locale":"en_US","og_type":"article","og_title":"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine - Energia nucleare","og_description":"StandardX raises \u00a310M to build a rare isotope refinery for oncology and nuclear fusion. First deliveries in 2027, industrial scale from 2029.","og_url":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/","og_site_name":"Energia nucleare","article_published_time":"2026-09-23T18:15:34+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/energianucleare.eu\/wp-content\/uploads\/2026\/09\/publish_09761b943ad14df6b0b82f9228258e13.jpg","type":"image\/jpeg"}],"author":"Redazione Energia Nucleare","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Redazione Energia Nucleare","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#article","isPartOf":{"@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/"},"author":{"name":"Redazione Energia Nucleare","@id":"https:\/\/energianucleare.eu\/en\/#\/schema\/person\/2c3f466ad139658dfa60c575cf287fb7"},"headline":"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine","datePublished":"2026-09-23T18:15:34+00:00","mainEntityOfPage":{"@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/"},"wordCount":457,"commentCount":0,"image":{"@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/energianucleare.eu\/wp-content\/uploads\/2026\/09\/publish_09761b943ad14df6b0b82f9228258e13.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/","url":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/","name":"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine - Energia nucleare","isPartOf":{"@id":"https:\/\/energianucleare.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#primaryimage"},"image":{"@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/energianucleare.eu\/wp-content\/uploads\/2026\/09\/publish_09761b943ad14df6b0b82f9228258e13.jpg","datePublished":"2026-09-23T18:15:34+00:00","author":{"@id":"https:\/\/energianucleare.eu\/en\/#\/schema\/person\/2c3f466ad139658dfa60c575cf287fb7"},"description":"StandardX raises \u00a310M to build a rare isotope refinery for oncology and nuclear fusion. First deliveries in 2027, industrial scale from 2029.","breadcrumb":{"@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#primaryimage","url":"https:\/\/energianucleare.eu\/wp-content\/uploads\/2026\/09\/publish_09761b943ad14df6b0b82f9228258e13.jpg","contentUrl":"https:\/\/energianucleare.eu\/wp-content\/uploads\/2026\/09\/publish_09761b943ad14df6b0b82f9228258e13.jpg","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/energianucleare.eu\/en\/standardx-raises-10-million-to-produce-rare-isotopes-for-fusion-and-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/energianucleare.eu\/en\/"},{"@type":"ListItem","position":2,"name":"StandardX raises \u00a310 million to produce rare isotopes for fusion and medicine"}]},{"@type":"WebSite","@id":"https:\/\/energianucleare.eu\/en\/#website","url":"https:\/\/energianucleare.eu\/en\/","name":"Energia nucleare","description":"Notizie sul nucleare","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/energianucleare.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/energianucleare.eu\/en\/#\/schema\/person\/2c3f466ad139658dfa60c575cf287fb7","name":"Redazione Energia Nucleare","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f7573bf636adfceb968c63d469c0889af0a78eb4935f321c17f76df121e056a6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f7573bf636adfceb968c63d469c0889af0a78eb4935f321c17f76df121e056a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7573bf636adfceb968c63d469c0889af0a78eb4935f321c17f76df121e056a6?s=96&d=mm&r=g","caption":"Redazione Energia Nucleare"},"url":"https:\/\/energianucleare.eu\/en\/author\/redazione\/"}]}},"_links":{"self":[{"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/posts\/3398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/comments?post=3398"}],"version-history":[{"count":0,"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/posts\/3398\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/media\/3395"}],"wp:attachment":[{"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/media?parent=3398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/categories?post=3398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/energianucleare.eu\/en\/wp-json\/wp\/v2\/tags?post=3398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}